abstract: Cumulus expansion and oocyte maturation are central processes in ovulation. Knowledge gained from rodent and other mammalian models has revealed some of the molecular pathways associated with these processes. However, the equivalent pathways in humans have not been thoroughly studied and remain unidentified. Compact cumulus cells (CCs) from germinal vesicle cumulus oocyte complexes (COCs) were obtained from patients undergoing in vitro maturation (IVM) procedures. Expanded CCs from metaphase 2 COC were obtained from patients undergoing IVF/ICSI. Global transcriptome profiles of the samples were obtained using state-of-the-art RNA sequencing techniques. We identified 1746 differentially expressed (DE) genes between compact and expanded CCs. Most of these genes were involved in cellular growth and proliferation, cellular movement, cell cycle, cell-to-cell signaling and interaction, extracellular matrix and steroidogenesis. Out of the DE genes, we found 89 long noncoding RNAs, of which 12 are encoded within introns of genes known to be involved in granulosa cell processes. This suggests that unique noncoding RNA transcripts may contribute to the regulation of cumulus expansion and oocyte maturation. Using global transcriptome sequencing, we were able to generate a library of genes regulated during cumulus expansion and oocyte maturation processes. Analysis of these genes allowed us to identify important new genes and noncoding RNAs potentially involved in COC maturation and cumulus expansion. These results may increase our understanding of the process of oocyte maturation and could ultimately improve the efficacy of IVM treatment.
Introduction
Late folliculogenesis and final oocyte maturation is a complex and highly regulated process. This process involves the reactivation of final cytoplasmatic maturation and oocyte meiosis, rupture of the follicle wall, cumulus expansion and tissue remodeling to form the corpus luteum. These processes are fundamental to the formation of an oocyte capable of fertilization and importantly also have an impact on the developmental potential of resultant embryos and successful pregnancy.
In vitro maturation (IVM) of oocytes is a promising technique that has the potential advantages of reducing treatments costs and averting the side effects of gonadotrophins required by conventional ovarian stimulation approaches (Piquette, 2006) . However, the efficiency of IVM of oocytes as a technology to assist clinical infertility treatment remains poor because of the reduced developmental potential of in vitro matured oocytes. Although the first IVM pregnancy was described .20 years ago (Cha et al., 1991) , pregnancy and live birth rates are lower than those of IVF. It is thought that the quality of the maturation process appears to be suboptimal since embryos resulting from in vivo matured oocytes have better developmental capacity when compared with their in vitro matured counterparts (Trounson et al., 2001; Piquette, 2006) . At present, during IVM, nuclear maturation occurs in 50-70% of oocytes, but cytoplasmic maturation is disturbed, leading to asynchrony between the cytoplasmic and nucleus compartments. There have been extensive efforts to elucidate the mechanisms that are responsible for the difference in the efficacy of in vitro and IVM (Sirard, 2011; Yerushalmi et al., 2011; Nogueira et al., 2012) . The study of the cumulus granulosa cell (GC) transcriptome has been proposed as a research approach with potential to lead to an improvement in the efficiency of IVM.
Inside the follicle, the oocyte is surrounded by GC populations that, during folliculogenesis, differentiate into both mural GCs and cumulus cells (CCs) (Richards and Pangas, 2010) . CCs are closer to the oocyte and maintain a close relationship via transzonal processes and gap junctions with the oocyte, providing nutrients, maturation-enabling factors and an optimal microenvironment to ensure successful maturation and further developmental competence. This close relationship between the oocyte and related CCs implies that transcriptome analysis of the CCs may serve as a marker for oocyte maturation and quality (Uyar et al., 2013) . Therefore, CCs gene expression has been studied at the mRNA and protein levels in different species to gain insight into the relationship between CCs and oocytes (Assou et al., 2006; Assidi et al., 2011; Regassa et al., 2011; Sirard, 2011; Xu et al., 2011; Borgbo et al., 2013) .
Several human and primate studies have indicated that the CC transcriptome is dysregulated during the IVM process (Lee et al., 2011; Ouandaogo et al., 2012; Guzman et al., 2013) . In a rhesus monkey transcriptome study, a large number of genes were oppositely regulated in IVM compared with IVF (Lee et al., 2011) . The human CC transcriptome after IVF differs significantly from the CC transcriptome after IVM (Ouandaogo et al., 2012) . It was suggested that such a difference is indicative of a delay in the acquisition of the mature CC phenotype following IVM. Several key factors related to meiotic maturation and oocyte competence were quantified in small antral follicles before and after IVM or IVF (Guzman et al., 2013) . It was found that genes encoding factors reflecting oocyte competence were significantly altered in IVM-CC compared with in vivo matured oocytes.
Several papers have described the changes in CC gene expression following the luteinizing hormone (LH) surge in primate, bovine and murine models (Hernandez-Gonzalez et al., 2006; Regassa et al., 2011; Xu et al., 2011) . An increasing number of human studies have shown correlations of CC gene expression with oocyte maturation, fertilization rate (McKenzie et al., 2004) and pregnancy outcome (Feuerstein et al., 2007; Hamel et al., 2008; Assou et al., 2010) . However, all of these studies have used only CCs from pre-ovulatory follicles that were previously exposed to human chorionic gonadotrophin (hCG) (Kenigsberg et al., 2009; de los Santos et al., 2012; Grondahl et al., 2012) or CC derived from cumulus oocyte complexes (COCs) matured in vitro (Ouandaogo et al., 2012) . We were unable to find any human study aimed at discerning differences in CC gene expression between immature COC derived from mid-antral follicles and COC obtained from mature follicles.
Long noncoding RNAs (lncRNAs) are currently defined as transcripts of .200 nucleotides without evident protein coding function (Rinn and Chang, 2012) . They are generally characterized by nuclear localization, low level of expression (Ravasi et al., 2006; Djebali et al., 2012; Kumar et al., 2013) and rapid transcriptional turnover (Kutter et al., 2012) . Their expression is strikingly tissue-specific compared with coding genes (Cabili et al., 2011; Djebali et al., 2012) , and they participate in multiple networks regulating gene expression and function (Gribnau et al., 2000; Martens et al., 2004; Ponting et al., 2009) . lncRNAs are emerging as key regulators of diverse cellular processes, and they have a significant impact on the development of human diseases (Calin et al., 2007; Yu et al., 2008; Huarte and Rinn, 2010; Kumar et al., 2013) . Antisense lncRNAs can affect expression of their host genes in several ways, for example by hybridization to their overlapping sense transcripts, which results in the formation of dsRNAs that are cleaved by Dicer to endogenous siRNAs. A role for endogenous siRNAs in mammalian oocytes has been demonstrated (Tam et al., 2008; Watanabe et al., 2008) .
Here, we used global transcriptome sequencing to characterize the final stages of follicular maturation and ovulation pathways in humans. The aim of this study was to identify genes and pathways that are differentially expressed (DE) between the cumulus of compact COC and expanded/stimulated COC.
We envisage that the elucidation of the control of gene expression involved in the final stages of follicular and oocyte maturation might help us to better understand the process of IVM, and consequently improve the results of this attractive procedure.
Materials and Methods
The study was approved by the local Institutional Review Board committee (ethical approval number 8707-11-SMC), and written informed consent was obtained from each patient. Patient demographics and baseline characteristic are presented in Table I .
IVF protocol
Normo-ovulatory patients aged 28 -39 undergoing IVF/ICSI due to male or preimplantation genetic-diagnosis were selected. Treatment protocols included the long agonist protocol or short antagonist protocol are described elsewhere (Elizur et al., 2005; Hourvitz et al., 2006) . When the leading follicles reached 18 mm in diameter, the patients received hCG (Ovitrelle 250 mg, Merck Serono). Oocyte retrieval was performed 36 h later by transvaginal ultrasound-guided needle aspiration. 
IVM protocol
Patients aged 31 -40 underwent an IVM cycle according to accepted IVM protocols (Fadini et al., 2009 ). On Day 3 of a spontaneous menstrual cycle, women underwent a baseline transvaginal ultrasound assessment to determine ovarian morphology, antral follicle count and endometrial thickness and basal blood concentrations of estradiol and progesterone were assessed. Following that, 150 IU/day rFSH were administered to the patients for 3 days. A second evaluation was performed on Day 6. An injection of 10 000 IU hCG (Pregnyl; Organon, Oss, Holland) was administered subcutaneously when the endometrial thickness was ≥5 mm and the leading follicle was at least 12 mm. Oocyte retrieval was performed 36 h later by transvaginal ultrasound-guided needle aspiration.
Isolation of CCs
Expanded CCs that surround metaphase 2 (M2) oocytes were obtained during the IVF/ICSI protocol (CCM2 sample). Oocytes were denuded mechanically using needles before the ICSI procedure. Compact CCs were obtained from surplus germinal vesicle (GV) oocytes that were acquired during IVM treatment (CCGV sample). Cells were centrifuged at 200 g for 5 min at room temperature and the resulting pellets were subjected to RNA purification.
For the RNA sequencing (RNAseq) experiment, we used CCs obtained from single oocyte (GV or M2) . For the qPCR experiments, purified CCs of two to three patients were separately pooled to form the CCGV and CCM2 groups. Pooled cells were subjected to total RNA purification. We grouped cumulus samples in order to reduce variation of samples due to the heterogeneity of patients and the low RNA amount retrieved from the cumulus of single COC.
Isolation of RNA
Total RNA was extracted from CCs by a Mini RNA Isolation I Kit (Zymo Research Corp., CA, USA), according to the manufacturer's instructions. Following isolation, total RNA integrity was tested with a Bioanalyzer (Agilent Technologies 2100). RNA was used for RNAseq and qPCR. The RNA concentrations for the CCGV samples and CCM2 samples were 3 -6 and 16 -50 ng/ml, respectively.
Generation of cDNA libraries and sequencing
Global transcriptome sequencing was performed on CCM2 samples obtained from three women and CCGV samples obtained from two women.
We used cDNA library preparation procedures recommended for highthroughput DNA sequencing on the Illumina Cluster Station and Genome Analyzer. mRNA was purified from total RNA using pre-prepared Sera-mag Magnetic Oligo(dT) Beads (Thermo Fisher Scientific, MA, USA).
The extracted mRNA was fragmented by incubating the samples at 708C for 5 min in the presence of fragmentation buffer (Ambion; catalog no. AM8740). The cDNA was synthesized using a SuperScript II Reverse Transcriptase Kit, 1 mg random primers and 10 U RNaseOUT (Invitrogen), 10 mM dNTP and 10 ng T4 Gene 32 (New England Biolabs; catalog no. M0300S) in a final reaction volume of 20 ml during the first-strand cDNA synthesis. Library preparation was performed following the Illumina recommendations (preparing samples for mRNA sequencing; Illumina). Quality and sizes of the products were checked using an Agilent DNA 1000 kit of the Bioanalyzer 2100 (Agilent Technologies), and each library had an insert size of 200 base pairs. Cluster generation and single-end sequencing was carried out using the standard Illumina procedures for the HiSeq 2000 sequencer (Illumina).
Expression analysis
After applying quality control check on the raw sequenced reads using the FastQC tool (Babraham Bioinformatics, Babraham Institute,Cambridge, UK), all sequenced reads were mapped and aligned to the human genome (hg19) using Tophat v1.3.3 software (Trapnell et al., 2009 ) with '-g 1' parameter to allow one alignment to the reference for a given read. A counting table was generated for all Ensembl genes (release 64). The summary of the total number of reads aligned to the genome and the transcriptome is listed in Supplementary Table SI .
The number of reads overlapping each of the annotated genes was counted using the HTSeq-count script from the HTSeq python package, using the 'union' overlap resolution mode. The count was done for genes and not for transcripts such that if a read overlaps with one or more exons of a gene, it is counted for this gene. DESeq v.1.8.3 within the Bioconductor framework, which was designed specifically to deal with small number of replicate experiments, was used for normalization, differential expression analysis and clustering (Anders and Huber, 2010) . Briefly, for normalization, a scaling factor was calculated for each sample. This factor was computed as the median of the ratio, for each gene, of its read count over its geometric mean across all samples. Raw read counts were then divided by the factor associated with their sequencing sample.
Cluster analysis was performed prior to the differential expression test for quality control. The Euclidean distance between samples was calculated from the variance stabilizing transformation of the count data, and hierarchical clustering was performed using the complete linkage method. Pearson correlation calculation was done after applying variance stabilizing transformation of the count data.
In order to increase detection power, independent filtering was done first by dropping 40% of genes whose counts overall were so small (an average count ,6) that they would have a negligible chance of being detected as DE (Bourgon et al., 2010) .
Next, a statistical test was applied on the 18 842 genes left after filtering using the DESeq methodology. Briefly, in order to compensate for the small number of replicates, the DESeq package assumes that genes with similar expression strength have similar variance, and so pools information from these in order to get a reasonable estimate of biological variability, which is then used for the test. P-values were calculated through a method that is analogous to a Fisher's exact test, but instead of assuming that the probabilities follow a hypergeometric distribution, they follow a negative binomial distribution parameterized from the mean and the estimated dispersion. The resulting P-values were corrected for multiple testing using the Benjamini and Hochberg approach, and genes having corrected P-values ,0.05 and fold change .2 were called as being DE. A detailed analysis pipeline is given in Supplementary Fig. S1 .
Sequencing data were deposited in GEO as: GSE50174.
Creation of genome browser images
The BEDTools (Quinlan and Hall, 2010) utilities were used to create 'bedgraph' files (see http://genome.ucsc.edu/goldenPath/help/bedgraph.html for definition) from the mapped data. First, the mapped 'bam' files output by Tophat were converted to bed format using 'bamTobed' utility with the-split parameter on. Next, the 'genomeCoverageBed' utility with the-bg parameter on was used in order to compute the read coverage among the genome and to create 'bedgraph' files. Next, we normalized the coverage data in the bedgraph files for the read density to be comparable between different samples. The normalization is done such that we got the pileup per 10 million reads in each sample. Finally, we used the UCSC utility, 'bedGraphToBigWig' (http://genome.ucsc.edu/goldenPath/help/ bigWig.html), in order to convert the bedgraph files to the bigwig format, which we have downloaded to the UCSC genome browser.
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Gene ontology, pathways and network analysis
The GOstats package (Falcon and Gentleman, 2007) from the Bioconductor framework was used for testing the over-and-under representation of GO terms in the list of DE genes (False Discovery Rate , 0.05). This was done using a conditional Hypergeometric test that uses the relationships among the GO terms for conditioning. As the universe group, we used all Ensembl genes that passed independent filtering (as described above) and were tested for differential expression.
Integration of gene expression data with molecular and chemical interactions and cellular phenotypes was performed using the ingenuity IPA platform (www.ingenuity.com). The list of DE genes was imported into Ingenuity, and each gene identifier was overlaid onto a global molecular network developed from information contained in the Ingenuity Pathways Knowledge Base. The IPA downstream effects analysis feature was used in order to identify whether significant biological process are increased or decreased based on the gene expression results. The upstream regulator analysis feature was used to predict upstream molecules, which may be causing the observed gene expression changes.
Validation of RNAseq results by quantitative RT-PCR
Expression level of 24 transcripts was measured by qPCR in CCGV and CCM2 samples. These transcripts were chosen for the validation of the RNAseq expression data. Samples of 1 ml (100 ng) of RNA solution was used for RT with a high-capacity cDNA RT kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. A power SYBR Green PCR mix (Applied Biosystems) was used for the PCR step. Amplification and detection were performed using the StepOnePlus real-time PCR system (Applied Biosystems) with the following profile: one cycle at 958C for 20 s and 40 cycles each at 958C for 3 s and 608C for 30 s. Samples of 1 ml of cDNA was used per reaction in a 10 ml reaction volume. All samples were done in duplicates. Actin, beta (ACTB) mRNA was chosen as a housekeeping gene. mRNA quantification were obtained by the comparative Ct method, using DDCt. The average Ct values for ACTB from the GV and M2 groups were 19.58 and 20.60, respectively. Results are expressed as fold change with respect to the experimental control that was set to 1. Student's t-test with a two-tailed distribution and two samples equal variance testing was used to compare samples for the normalization of data. For all statistical analysis of qPCR, SPSS 20 software (IBM, Armonk, NY, USA) was used. Difference in measurable gene expression .2-fold was considered biologically significant and P-values ,0.05 was considered statistically significant. The primers that were used in this work are listed in Supplementary Table SII.
Results

Sequencing of short expressed reads from compact and expanded CCs
Illumina-based RNAseq was carried out on RNA extracted from two samples of compact (CCGV) and three samples of expanded (CCM2) CCs. A total of 499.5 million reads were generated on an Illumina HiSeq2000 instrument, including 129.6 million reads from CCGV and 369.9 million reads from CCM2. At least 60.8 million reads were generated from each sample, with an average of 99.9 million reads per library. Reads were mapped to the human genome (hg19) using Tophat software. On average, 70% of reads in each sample were mapped to the human genome. After genomic locations were obtained for each mapping read, we next used HTSeq-count script in order to count the number of reads aggregated over each annotated gene (Ensembl version 64), where each gene is considered as the union of all its exons. Between 84 and 91% of mapping reads were aggregated within 31 445 annotated genes and on average, 85% uniquely overlapped to genes.
General characteristics of gene expression
With the RNAseq data inspected, all quality control parameters were within the acceptable ranges (see Materials and Methods), these include unsupervised hierarchical cluster analysis, which shows that the biological replicates cluster to their corresponding groups (Fig. 1A) .
Prior to differential expression analysis, and in order to enable accurate comparisons of expression level between samples, the digital read count of every gene was normalized. Next, in order to increase detection power, an independent filtering was applied by dropping genes with very low count overall (see Materials and Methods).
A total of 18 842 annotated Ensembl genes passed the independent filtering and were included in subsequent analysis.
The follicle stimulating hormone receptor (FSHR) gene was chosen as a representative of genes not expressed in CCM2 cells (Grondahl et al., 2011) . Since its normalized expression value in our dataset was 75, this value was chosen as an expression cutoff. All genes with expression value above this cutoff were considered as expressed.
A total of 14 010 genes were expressed in the compact CCs (CCGV), and 14 202 genes were expressed in the expanded CCs (CCM2). AVenn diagram of these two gene lists is shown in Fig. 1B , illustrating the numbers of selective and co-expressed genes in the two conditions. The genes comprising the compartments of the Venn diagram are given in Supplementary Table SIII. Differential expression analysis (see Materials and Methods) revealed dramatic changes in the CCs transcriptome during the CC expansion/ maturation process. A total of 1746 genes were DE (10.2% of annotated Ensembl genes identified) between compact and expanded CCs with a fold change .2, and adjusted P-value ,0.05 (Fig. 1C ). Of these, 1145 genes changed .10-fold, 451 changed between 5-and 10-fold, whereas the rest (150 genes) changed between 2-and 5-fold.
Our results indicated that a total of 1100 genes (6.4% of annotated genes) were up-regulated in the expanded CC cells, including genes involved in LH signaling, oocytes maturation and cumulus expansion, while 646 genes (3.8% of annotated genes) were down-regulated. The ten most abundant genes in each sample are listed in Table II . None of the lists of expressed genes represented the common leukocyte antigen CD45 Protein tyrosine phosphatase, receptor type, C indicating that there is no or negligible blood contamination to the samples.
Validation of selected mRNA levels as estimated by qPCR and RNAseq
We used qPCR analysis to validate the results obtained by RNAseq. We selected genes that were identified as DE by RNAseq and are known to be involved in various pathways and processes of cumulus expansion and maturation. The genes selected included matrix and gap junction molecules (ADAMTS1, GJA1), signaling cascades molecules (FSHR, LHCGR, BMPR2, PTGS2, SFRP4 and NOS2), steroidogenesis (CYP19, STAR), putative oocyte quality markers (GREM1, GPX3) and genes of unknown ovarian function (transmembrane 4 L6 family member 1 (TM4SF1), angiomotin-like protein 1 (AMOTL1) and tolloid-like 2 (TLL2)). qPCR was performed in three different experiments as shown in Fig. 2 and demonstrated agreement with the RNAseq relative expression data.
Gene ontology analysis
Gene ontology (GO) analysis of DE genes revealed a number of cellular processes regulated during the periovulatory interval. The most significant GO terms overrepresented in DE genes are listed in Supplementary Table SIV. The most highly represented processes were phospholipid efflux (83% of genes), positive regulation of macrophage activation (83%), nitric oxide-mediated signal transduction (78%), mitotic chromosome condensation (54%), hydrogen peroxide catabolic process (50%), regulation of transcription involved in G1/S phase of mitotic cell cycle (48%) and eicosanoid transport (47%).
We used Ingenuity IPA downstream effect analysis to identify whether significant downstream biological processes were increased or decreased based on the direction of change of the genes in our Figure 1 Cluster analysis. The cluster dendrogram (A) shows how the CCGV and CCM2 samples cluster in separate clusters. The Venn diagram (B) of genes expressed in compact CCs from GV oocytes (CCGV) and expanded CC from M2 oocytes (CCM2) divided to represent either specific or overlapping genes between the cell populations. Hierarchical cluster of genes (C) selected as being differentially expressed (fold change 2, P , 0.05, Benjamini -Hochberg correction) between the compact CCs (two women) and the expanded CCs (three women). The intensity of the pseudocolors reflects relative gene expression level.
Cumulus cell transcriptome during follicular maturation Mean expression levels across replicates were calculated based on normalized counts. Common genes in the two lists are printed in bold. CCGV: compact cumulus cells from germinal vesicles; CCM2: expanded cumulus cells from metaphase 2 oocytes. The fold change is the difference in expression levels between CCGV and CCM2. Figure 2 Validation of RNAseq results by qPCR in seven women in three separate experiments. Total mRNA was purified from CCs denuded from GV COC aspirated during IVM procedures (CCGV) and CCs denuded from M2 COC (CCM2) aspirated during IVF procedures. The mRNAs were subjected to qPCR in duplicates with examined genes and b-actin primers. Gene expression was calculated relative to b-actin level in the same sample and expression levels were compared using Student's t-test. The difference reached a level of significance (P , 0.05) for all tested genes. Results of RNAseq (blue) and qPCR (red) are presented as log2 fold change between CCM2 and CCGV samples.
dataset. The results, visualized as a heat map (Fig. 3) , indicate the relative expression was increased in five and decreased in three major biological processes. The processes include cellular movement, inflammatory response, immune cell trafficking, tissue development and lipid metabolism (increased) and tissue morphology, DNA replication and cell cycle (decreased). A comprehensive list of genes associated with each GO theme was generated (see Suppmentary Table  SV) . These results are in agreement with previous studies performed in animal models.
Correlation between DE genes and CC markers of oocyte quality/embryo competence As CCs can be obtained easily before the ICSI procedure or before insemination for standard IVF, several groups have used microarray technologies and quantitative RT -PCR analyses to link the CC gene expression profile with oocyte quality and/or embryo competence and/or pregnancy outcome. In the present study, we used RNAseq to characterize genes involved in the final stages of follicular maturation and ovulation pathways. Based on the assumption that in vivo COC maturation is related to healthy competent oocytes, we chose to compare the cumulus genes we found to be regulated during oocyte maturation to CC genes related to oocyte quality.
We conducted an extensive literature search to assemble and compare a list of 56 human genes to the gene expression profiles that we generated (see Supplementary Table SVI) . From the generated list, 13 genes (22%) were highly regulated (.2-fold change, adj. P , 0.06) in our experiment and are listed in Table III (hypergeometric test, P , 0.001).
Transcription regulators of cumulus expansion and maturation genes
Using Ingenuity's IPA upstream regulator analytic feature, we identified a cascade of transcriptional regulators in the promoter regions of the DE genes, which may control the gene expression involved in cumulus expansion and maturation. These transcription regulators must play an important role in this process. A total of 140 upstream regulators were identified. In 28 of these (Table IV) , the predicted activation state was suggested (bias-corrected z-score .+2).
Among the transcription regulators that were significantly represented in this analysis was cyclin-dependent kinase inhibitor 2A (CDKN2A, p16   INK4A ). The CDKN2A gene was also up-regulated in our analysis (16-fold, P ¼ 0.018).
Other putative transcription factors and regulators identified included additional CDK complex members such as TP53, Rb and E2F. Several genes with estrogen receptor response elements in their promoter region predict that estrogen receptor signaling has an inhibiting role, affecting CC genes in the maturation/expansion process (Table IV) .
Identification of DE lncRNAs
In order to test if lncRNAs might have functional roles in follicular development and maturation, we searched the DE gene list for known lncRNAs. We found that of 1746 DE genes, 89 ( 5%) are annotated as lncRNAs (44 long intergenic RNAs (lincRNAs) and 45 antisense transcripts of genes). Of the DE lncRNAs, 28 were up-regulated and 61 were down-regulated in CCM2 samples.
Of the genes with DE antisense lncRNAs, 17 were also DE between the CCGV and CCM2 samples (one up-regulated and 16 downregulated in CCM2). Interestingly, 12 of the antisense transcripts are located within the introns of genes known to be involved in GC physiology, including ADAMTS9, AQP2, AQP5, CACNA1C, CHRM3, DPP4, FABP6, GPC5, HAS2, HSD11B1, ITGA6 and WNT5A (Table V) . We have validated the differential expression of seven lncRNAs (four antisense and three lincRNAs, Fig. 4 and Supplementary Fig. S2 ).
Discussion
Late folliculogenesis and final oocyte maturation is a complex and highly regulated process. The oocyte and surrounding CCs undergo extensive changes in structure and function in preparation for ovulation and fertilization. While this process has been extensively studied in murine, bovine and primate models, data in humans are limited.
Therefore, the aim of our study was to carry out an extensive study of the dynamics of the CC transcriptome during late folliculogenesis in order to identify the genes and pathways involved in the final stages of follicular maturation and ovulation. Elucidating these molecular pathways might help to improve the IVM process and achieve better results in ART by helping to further develop the IVM approach.
Recently, Ouandaogo et al. (2012) studied the CC transcriptome from CC surrounding GV, MI and M2 stage oocytes matured in vivo and in vitro. All samples were luteinized CC and included samples from polycystic ovary syndrome (PCOS) patients, which could affect the cumulus transcriptome. There have been other published works that have examined the human CC transcriptome from IVM or IVF procedures (Zhang et al., 2005; Assou et al., 2006; van Montfoort et al., 2008; Kenigsberg et al., 2009; Assidi et al., 2011; Ouandaogo et al., 2012) . However, all of these investigations compared CC obtained from in vitro matured COC with CC of controls matured in vivo, thus limiting our ability to explore the actual changes in the CC transcriptome during CC expansion and maturation. Our model enabled us to evaluate the effect of final in vivo oocyte maturation. Our data indicate that indeed CC undergo significant changes during this relatively short period of time: over 1700 of the expressed genes (10.2%) are significantly regulated, most of them by .10-fold change.
In this study, we chose to explore two critical time points relevant to IVM: compact CCs obtained from 12 mm follicles containing GV oocytes (the starting point in the IVM process) and expanded CCs obtained from 18 mm follicles containing M2 oocytes matured in vivo (the ideal IVM endpoint). During the interval between these two maturation stages, several important processes take place: the processes of late folliculogenesis with the final stages of follicular maturation from mid-antral to preovulatory follicle, and the LH/hCG effect over 36 h until just before the rupture of the follicle and ovulation.
We assume that genes which are DE in our experiment are those involved in late folliculogenesis and ovulation and that, therefore, the relevant gene pathways are also crucial to the IVM process.
The CCGV cells used in this study were exposed to hCG. However, they were chosen due to the limited availability of human material from immature GV COC. Nevertheless, from our broad experience and others (Maman et al., 2012; Guzman et al., 2013) with these cells, we have observed that the small follicles do not respond to the LH surge and remain as compact cumulus (both visually and at the molecular level of cumulus expansion gene expression) and that the oocyte remains at the GV stage. Taken together, we believe that these specific follicles, in which the oocyte remained at the GV stage and cumulus expansion did not occur, the GCs indeed do not express the LHCGR and do not respond to it; thus, hCG administration had no effect on these CCs.
Another limitation to our study is the small sample size used for RNAseq. To overcome this, we employed stringent inclusion and exclusion criteria; we specifically attempted to minimize the potential for RNAseq to be confounded by inclusion of conditions, for which prior gene expression signature profiles have been suggested, such as endometriosis, PCOS, and the presence of hydrosalpinges. We also validated the RNAseq results using qPCR in over 25 different genes of known and unknown ovarian function. Cumulus cell transcriptome during follicular maturation Lee et al. (2011) performed a microarray analysis of the cumulus transcriptome during in vivo maturation and IVM of rhesus monkey oocytes. They described 71 genes that significantly changed by .10-fold during in vivo maturation of oocytes. Of these genes, 43% were also represented in the list of genes that were significantly changed (2-fold) in our human CCM2 transcriptome.
The current work has adopted a whole transcriptome sequencing approach to characterize the CC transcriptome. This method allowed us to identify and quantify more genes than do microarray methods. Additionally, it gave us the ability to estimate the actual copy number of each gene compared with the relative fluorescence results acquired by microarray technique. In addition, our experimental design included selective verification of mRNA levels within the same tissue samples using qPCR based on the current literature from animal models to gene activities and functions anticipated in humans. We validated the RNAseq results using qPCR on a number of genes with known ovarian function in several aspects of follicular development. We also examined several unknown ovarian genes including TM4SF1, AMOTL1 and TLL2.
TM4SF1 was up-regulated in CCM2 cells. It has been found to be androgen receptor target in human prostate cancer cells and involved in cancer cell migration and invasion (Allioli et al., 2011) as well as in endothelial cell migration (Zukauskas et al., 2011) . It functions a molecular organizer that interacts with membrane and cytoskeleton-associated proteins and uniquely initiates the formation of nanopodia and facilitates cell polarization and migration (Zukauskas et al., 2011) , which suggest a putative important role in cumulus expansion and ovulation.
AMOTL1 was up-regulated in CCM2 cells. It is a paralog of amotilin, which was originally identified as a binding partner of angiostatin, and was found to regulate endothelial cell migration through angiostatin binding (Bratt et al., 2005) . In addition, AMOTL1 was shown to be a part of the actin cytoskeleton and cell-to-cell junction complexes. It is known to interact and regulate the Yes-associated protein 1 oncogene of the hippo pathway (Wang et al., 2011) , which was recently shown to be involved in regulation of ovarian reserve (Kawamura et al., 2013) .
TLL2 was down-regulated in CCM2 cells. It is a protease highly similar to bone morphogenetic protein 1 (BMP1) metalloproteinase of the astacin family. TLL2 and BMP1 play a key role in regulating the formation of the extracellular matrix, particularly by processing the C-propeptide of fibrillar procollagens. BMP1 has been found in ovine GCs and in follicular fluid (Canty-Laird et al., 2010) .
GO analysis allows us to further characterize the different molecular and cellular functions, processes, compartments and domains that are involved in cumulus expansion and maturation (Harris et al., 2004) . Our results further corroborate the extensive changes that occur during cumulus expansion and maturation. Processes that are positively regulated include cellular movement, lipid metabolism, inflammatory response and immune cell trafficking. Akison et al. (2012) has demonstrated that CCs in the expanded COC transition to an adhesive, motile and invasive phenotype in the periovulatory period similar to MB-231 invasive breast cancer cell line, which is in agreement with the increased cellular movement observed in CCM2 samples.
Processes that are negatively regulated final follicular maturation include the cell cycle and DNA replication. These changes demonstrate the shift of CCs from the immature proliferating stage toward a more specialized mature condition. Our results are similar to results obtained in animal models including mouse, bovine and primates (HernandezGonzalez et al., 2006; Lee et al., 2011; Regassa et al., 2011; Xu et al., 2011) .
It has been suggested that CCs continue to proliferate for a limited period after the ovulatory stimulus, thereby leading to cumulus expansion followed by cell cycle arrest. In the mouse, CCs are highly mitotic for a few hours after hCG administration and then stop dividing after 16 -24 h concomitantly with maturation (Hernandez-Gonzalez et al., 2006; Fru et al., 2007) . The CC samples we analyzed were derived from periovulatory follicles 36 h after the hCG maturation signal and therefore these cells are expected to be in cell cycle arrest.
Cell cycle regulation is complex and involves positive regulators such as cyclins and CDKs and also negative regulators such as CDK inhibitors. There are two groups of inhibitors: CDKN2A also known as INK4 (Canepa et al., 2007) . CDKN2A is an important negative regulator of cell cycle progression. CDKN2A has direct as well as indirect effect on E2Fs through inhibition of Cdk4, which inhibits E2F inhibitor Rb (Eymin et al., 2001; Canepa et al., 2007) . Indeed, our results demonstrate the inhibition of E2Fs function, as well as activation of Rb activity (see Table IV ). The effects of p15 INK4B and p16INK4A of the INK family and p21
Cip1 and p27 Kip1 of the Cip/Kip family on rodent folliculogenesis have been studied (Bayrak and Oktay, 2003) . In rats, p27 kip1 and p21 cip1 up-regulation and cyclin D2 down-regulation lead to proliferation arrest following hCG triggering (Robker and Richards, 1998) . It was previously shown that growth differentiation factor 9 (GDF9) treatment of human luteinized GCs stimulates proliferation and cell cycle progression through inhibition of CDKN2A (Huang et al., 2009) . Our results further show that CDKN2A expression in cumulus GC is increased during expansion and maturation and that a large number of DE genes have potential promoter CDKN2A binding sites (Table VI) . Among CDKN2A targets were genes positively associated with cell cycle progression and proliferation (ASF1B,URKB, CDC25A, CDK1, CDK2, CENPK, FANCA, FBXO5, FBXO5, FHL2, HUNK, MCM4, MCM7, MCM8, MELK, RAD51AP1) that were all down-regulated suggesting CDKN2A is a major player in the differentiation and growth arrest of human CCs in the periovulatory period.
Other potential CDKN2A targets that were up-regulated during CC maturation/expansion includes PTX3, NR3C1 (glucocorticoid receptor) and APPL2 (adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing two).
PTX3 is an important component of the cumulus expansion process (Salustri et al., 2004) , NR3C1 has been shown to play a role in suppression of apoptosis in bovine corpus luteum (Komiyama et al., 2008) and APPL2 has been identified as a binding partner of FSHR in complex with akt2 and FOXO1a (Nechamen et al., 2007) and has a possible role in FSH signaling. Taken together, these results suggest that CDKN2A plays a major role in the arrest of proliferation and maturation of human CC during final folliculogenesis.
Based on the assumption that normal COC maturation is related to healthy competent oocytes, we chose to compare the list of genes regulated during CC maturation/expansion to genes expressed in CC that considered markers of oocyte quality. We found that many of the genes regulated in this process are indeed also related to oocyte quality and embryo developmental potential. Thus, we believe that this library of genes can be used to identify novel markers of oocyte quality.
Recently, several studies have shown that miRNA may play an important role in female fertility and in the regulation of oocyte and CC crosstalk (Mishima et al., 2008; Assou et al., 2013; Donadeu and Schauer, 2013; Velthut-Meikas et al., 2013) . However, to the best of our knowledge, no study has tested the involvement of other noncoding RNAs in folliculogenesis and ovulation.
We have found a large number of DE lncRNAs between CCGV and CCM2 cells. One of the lncRNAs that were found to be up-regulated in CCM2 cells is AC078883.3 (ITGA6-AS), antisense to integrin alpha-6 (ITGA6). Interestingly, its host gene (ITGA6) was found to be significantly down-regulated (3-fold) in CCM2.
Integrins are integral cell-surface proteins, composed of an alpha chain and a beta chain that known to participate in cell adhesion as well as cell-surface-mediated signaling. Integrin a6/b1 is the receptor for laminin on GCs and it has been shown that the interaction between them in GCs enhances survival and proliferation and modulates steroidogenesis (Le Bellego et al., 2002) . Whether the ITGA6 antisense lncRNA directly regulates the expression of its ITGA6 host gene requires further investigation.
Another antisense lncRNA that was found to be expressed only in CCM2 cells is FAM83A-AS. Additionally, FAM83A itself is expressed only in CCM2. Recently, FAM83A was shown to be involved in modulating EGFR signaling in cancer in murine models in vivo and in vitro. FAM83A interacted with and caused phosphorylation of c-RAF and PI3K p85, upstream of MAPK and downstream of EGFR and was shown to confer resistance to EGFR -tyrosine kinase inhibitors (EGFR-TKIs) (Lee et al., 2012) . EGF and EGF-like molecules play a major role in CCs physiology (Fru et al., 2007; Richards and Pangas, 2010 ) and FAM83A and FAM83A-AS might be involved in their regulation in GCs.
We identified that RP13-49115.3 lncRNA is down-regulated in CCM2 compared with CCGV. Interestingly, miR202, which is expressed as an intron of this lncRNA, is also down-regulated. This miRNA is highly enriched in the mammalian gonad (Mishima et al., 2008; Bannister et al., 2011) . In early development, it is a regulator of SOX9 in gonadal differentiation and its expression is influenced by estrogen (Bannister et al., 2011) . Increased miR-202-5p expression in chicken gonads correlates with down-regulation of FOXL2 and aromatase and up-regulation of DMRT1 and SOX9 (Bannister et al., 2011) . miR202 expression in follicular fluid is higher in an ovulatory equine follicles compared with ovulatory follicles (Donadeu and Schauer, 2013) . In human GCs, it is up-regulated in cumulus GC compared with mural GC (Velthut-Meikas et al., 2013) . It was recently reported to function as a tumor suppressor gene in gastric cancer and is down-regulated in cancer tissue. Overexpression of miR-202-3p in gastric cancer cells caused suppressed cell proliferation and induced cell apoptosis (Zhao et al., 2013) .
We also found that CHRM3-AS2 lncRNA, antisense-to-cholinergic receptor muscarinic 3 (CHRM3), is up-regulated in CCM2 compared with CCGV, as well as its host gene. It has been shown that primate ovaries produce acetylcholine (ACh) and express CHRM3 (Fritz et al., 2001) , and it has been further suggested that ACh can modulate gonadotrophin induced estrogen and progesterone secretion from cultured GCs (Kornya et al., 2001 ).
In conclusion, using global transcriptome sequencing, we were able to generate a library of genes regulated during cumulus expansion and oocyte maturation processes. Analysis of these results allowed us to identify new important genes, transcription factors and noncoding RNAs potentially involved in COC maturation and cumulus expansion, and may help us better understand the in vivo and IVM process. This work has the potential to contribute to improve the process of IVM of immature oocytes utilized in IVM cycles.
